Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis H Miller

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
NPJ Vaccines|August 15, 2017
A malaria vaccine protects <i>Aotus</i> monkeys against virulent <i>Plasmodium falciparum</i> infectionPrakash Srinivasan, G Christian Baldeviano, Kazutoyo Miura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individualsPeter D Crompton, Marko Mircetic, Greta Weiss, et al.
Plos One|October 18, 2007
Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult MaliansAlassane Dicko, David J Diemert, Issaka Sagara, et al.
Vaccine|October 31, 2009
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adultsIssaka Sagara, Ruth D Ellis, Alassane Dicko, et al.
The Journal of Infectious Diseases|October 18, 2013
Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malariaTuan M Tran, Aissata Ongoiba, Jill Coursen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarrayPeter D Crompton, Matthew A Kayala, Boubacar Traore, et al.
Vaccine|May 12, 2009
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliIssaka Sagara, Alassane Dicko, Ruth D Ellis, et al.
Journal of the American College of Cardiology|October 18, 2014
Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomesNils P Johnson, Gábor G Tóth, Dejian Lai, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
NPJ Vaccines|August 15, 2017
A malaria vaccine protects <i>Aotus</i> monkeys against virulent <i>Plasmodium falciparum</i> infectionPrakash Srinivasan, G Christian Baldeviano, Kazutoyo Miura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individualsPeter D Crompton, Marko Mircetic, Greta Weiss, et al.
Plos One|October 18, 2007
Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult MaliansAlassane Dicko, David J Diemert, Issaka Sagara, et al.
Vaccine|October 31, 2009
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adultsIssaka Sagara, Ruth D Ellis, Alassane Dicko, et al.
The Journal of Infectious Diseases|October 18, 2013
Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malariaTuan M Tran, Aissata Ongoiba, Jill Coursen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarrayPeter D Crompton, Matthew A Kayala, Boubacar Traore, et al.
Vaccine|May 12, 2009
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliIssaka Sagara, Alassane Dicko, Ruth D Ellis, et al.
Journal of the American College of Cardiology|October 18, 2014
Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomesNils P Johnson, Gábor G Tóth, Dejian Lai, et al.
Pageof 17